Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25586821.
- Also identified by DOI 10.1002/adhm.201400670.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Under ultralow radiofrequency (RF) power, transferrin-conjugated graphene nanoparticles can thermally ablate drug- or radiation-resistant cancer cells very effectively. The results suggest that graphene-based RF hyperthermia can be an efficient method to manage drug-/radiation-resistant cancers.
Medical subject headings
- Antineoplastic Agents
- Biocompatible Materials
- Cell Survival
- Graphite
- Radio Waves